Results 151 to 160 of about 43,288 (214)

Safety profile and signal detection of tadalafil: a real-world analysis based on the Food and Drug adverse event reporting system. [PDF]

Sex Med
Li J, Li K, Yang S, Chen Y, Ren P, Deng G, Lei L, Ma Q, Yang H, Deng L.   +9 more
europepmc   +1 more source

Pulmonary pathology of PRRS

, 2021
openaire   +1 more source

Identifying Sex Differences in Adverse Events Reported on Opioid Drugs in the FDA's Adverse Event Reporting System (FAERS). [PDF]

Pharmaceuticals (Basel)
Aslam A, Hong H, Patterson TA, Guo W.
europepmc   +1 more source

Current Understanding of Cell-Surface Immune Receptors for MAMPs and Plant Parasites in the Solanaceae Family. [PDF]

Mol Plant Pathol
Leuschen-Kohl R, Iyer-Pascuzzi AS.
europepmc   +1 more source

Immune-Related Adverse Events in Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors: Insights From a FAERS Disproportionality Analysis. [PDF]

Cancer Med
Gokhale P, Zapata LV.
europepmc   +1 more source

Signal detection of drug-induced esophageal ulcer across 20 years of real-world study: Focus on 49 high-risk medicines. [PDF]

J Int Med Res
Zheng W, Jin LY, Hu J, Wang JY, Mao KL, Jiang Q.   +5 more
europepmc   +1 more source

Ketoacidosis Risk in Non-diabetic Patients Using Semaglutide Versus Tirzepatide for Obesity: A Disproportionality Analysis of the FDA Adverse Event Reporting System. [PDF]

Cureus
Makhmutov A, Qureshi F.
europepmc   +1 more source

Using Next Generation Chemiluminescent Probes to Improve the <i>Plasmodium falciparum</i> <i>in vitro</i> Parasite Reduction Ratio (PRR) Assay. [PDF]

ACS Infect Dis
Hellingman A, Göttle NL, Walz A, Brancucci NMB, Wittlin S, Mäser P, Rottmann M.   +6 more
europepmc   +1 more source

Class-level drug safety surveillance in hospital practice: A pharmacovigilance analysis of 84 therapeutic subclasses from a South Asian tertiary care center. [PDF]

Explor Res Clin Soc Pharm
Umer A, Mohmand AK, Khan NM, Arshad A, Sethi SM.   +4 more
europepmc   +1 more source